Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function

References

• Roth GJ, Hickey MJ, Chung DW, Hickstein DD. Circulating human blood platelets retain appreciable amounts of poly (A)+ RNA. Biochem Biophys Res Commun 1989;160(2):705–710
   Google Scholar
• Rowley JW, Oler AJ, Tolley ND, Hunter BN, Low EN, Nix DA, Yost CC, Zimmerman GA, Weyrich AS. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 2011;118(14):e101–e111
   PubMed Web of Science ®Google Scholar
• Ts'ao CH. Rough endoplasmic reticulum and ribosomes in blood platelets. Scand J Haematol 1971;8(2):134–140
   PubMedGoogle Scholar
• Kieffer N, Guichard J, Farcet JP, Vainchenker W, Breton-Gorius J. Biosynthesis of major platelet proteins in human blood platelets. Eur J Biochem 1987;164(1):189–195
   PubMedGoogle Scholar
• Booyse FM, Rafelson ME Jr. Studies on human platelets. I. synthesis of platelet protein in a cell-free system. Biochim Biophys Acta 1968;166(3):689–697
   Google Scholar
• Weyrich AS, Dixon DA, Pabla R, Elstad MR, McIntyre TM, Prescott SM, Zimmerman GA. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci U S A 1998;95(10):5556–5561
   PubMed Web of Science ®Google Scholar
• Evangelista V, Manarini S, Di Santo A, Capone ML, Ricciotti E, Di Francesco L, Tacconelli S, Sacchetti A, D'Angelo S, Scilimati A, et al. De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin. Circ Res 2006;98(5):593–595
   PubMed Web of Science ®Google Scholar
• Edelstein LC, Bray PF. MicroRNAs in platelet production and activation. Blood 2011;117(20):5289–5296
   PubMed Web of Science ®Google Scholar
• Osman A, Falker K. Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes. Platelets 2011;22(6):433–441
   PubMed Web of Science ®Google Scholar
• Ple H, Landry P, Benham A, Coarfa C, Gunaratne PH, Provost P. The repertoire and features of human platelet microRNAs. PLoS One 2012;7(12):e50746
   PubMed Web of Science ®Google Scholar
• Landry P, Plante I, Ouellet DL, Perron MP, Rousseau G, Provost P. Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol 2009;16(9):961–966
   PubMed Web of Science ®Google Scholar
• Bruchova H, Merkerova M, Prchal JT. Aberrant expression of microRNA in polycythemia vera. Haematologica 2008;93(7):1009–1016
   PubMed Web of Science ®Google Scholar
• Nagalla S, Shaw C, Kong X, Kondkar AA, Edelstein LC, Ma L, Chen J, McKnight GS, Lopez JA, Yang L, et al. Platelet microRNA–mRNA coexpression profiles correlate with platelet reactivity. Blood 2011;117(19):5189–5197
   PubMed Web of Science ®Google Scholar
• Kondkar AA, Bray MS, Leal SM, Nagalla S, Liu DJ, Jin Y, Dong JF, Ren Q, Whiteheart SW, Shaw C, et al. VAMP8/endobrevin is overexpressed in hyperreactive human platelets: Suggested role for platelet microRNA. J Thromb Haemost 2010;8(2):369–378
   PubMed Web of Science ®Google Scholar
• Wollowitz S. Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma. Semin Hematol 2001;38(4 Suppl 11):4–11
   PubMed Web of Science ®Google Scholar
• McCullough J, Vesole DH, Benjamin RJ, Slichter SJ, Pineda A, Snyder E, Stadtmauer EA, Lopez-Plaza I, Coutre S, Strauss RG, et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: The SPRINT trial. Blood 2004;104(5):1534–1541
   PubMed Web of Science ®Google Scholar
• Klein HG, Anderson D, Bernardi MJ, Cable R, Carey W, Hoch JS, Robitaille N, Sivilotti ML, Smaill F. Pathogen inactivation: Making decisions about new technologies. Report of a consensus conference. Transfusion 2007;47(12):2338–2347
   Google Scholar
• Kerkhoffs JL, van Putten WL, Novotny VM, Te Boekhorst PA, Schipperus MR, Zwaginga JJ, van Pampus LC, de Greef GE, Luten M, Huijgens PC, et al. Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction. Br J Haematol 2010;150(2):209–217
   PubMed Web of Science ®Google Scholar
• van Rhenen D, Gulliksson H, Cazenave JP, Pamphilon D, Ljungman P, Kluter H, Vermeij H, Kappers-Klunne M, de Greef G, Laforet M, et al. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: The euroSPRITE trial. Blood 2003;101(6):2426–2433
   PubMed Web of Science ®Google Scholar
• Mirasol Clinical Evaluation Study Group. A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology. Transfusion 2010;50(11):2362–2375
   Google Scholar
• Vamvakas EC. Meta-analysis of the randomized controlled trials of the hemostatic efficacy and capacity of pathogen-reduced platelets. Transfusion 2011;51(5):1058–1071
   Google Scholar
• Vamvakas EC. Meta-analysis of the studies of bleeding complications of platelets pathogen-reduced with the Intercept system. Vox Sanguinis 2012;102(4):302–316
   PubMed Web of Science ®Google Scholar
• Snyder E, McCullough J, Slichter SJ, Strauss RG, Lopez-Plaza I, Lin JS, Corash L, Conlan MG. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: The SPRINT trial. Transfusion 2005;45(12):1864–1875
   PubMed Web of Science ®Google Scholar
• Butler C, Doree C, Estcourt LJ, Trivella M, Hopewell S, Brunskill SJ, Stanworth S, Murphy MF. Pathogen-reduced platelets for the prevention of bleeding. Cochrane Database Syst Rev 2013;3:CD009072
   PubMed Web of Science ®Google Scholar
• Fang Z, Du R, Edwards A, Flemington EK, Zhang K. The sequence structures of human microRNA molecules and their implications. PLoS One 2013;8(1):e54215
   PubMed Web of Science ®Google Scholar
• Saini HK, Enright AJ, Griffiths-Jones S. Annotation of mammalian primary microRNAs. BMC Genomics 2008;9:564
   Google Scholar
• Hitzler W, Vamvakas EC. Platelet microRNA profiles and the effect of pathogen reduction on platelet function. Clin Lab 2011;57(7–8):451–454
   Google Scholar
• Bruchmuller I, Janetzko K, Bugert P, Mayaudon V, Corash L, Lin L, Kluter H. Polymerase chain reaction inhibition assay documenting the amotosalen-based photochemical pathogen inactivation process of platelet concentrates. Transfusion 2005;45(9):1464–1472
   Google Scholar
• Apelseth TO, Bruserud O, Wentzel-Larsen T, Bakken AM, Bjorsvik S, Hervig T. In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage. Transfusion 2007;47(4):653–665
   PubMedGoogle Scholar
• Perez-Pujol S, Tonda R, Lozano M, Fuste B, Lopez-Vilchez I, Galan AM, Li J, Goodrich R, Escolar G. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates. Transfusion 2005;45(6):911–919
   PubMed Web of Science ®Google Scholar
• Johnson L, Loh YS, Kwok M, Marks DC. In vitro assessment of buffy-coat derived platelet components suspended in SSP+ treated with the Intercept blood system. Transfusion Med 2013;23(2):121–129
   Google Scholar
• Carvalho H, Alguero C, Santos M, de Sousa G, Trindade H, Seghatchian J. The combined effect of platelet storage media and intercept pathogen reduction technology on platelet activation/activability and cellular apoptosis/necrosis: Lisbon-RBS experience. Transfusion and apheresis science: Official journal of the World Apheresis Association: Official journal of the European Society for Haemapheresis 2006;34(2):187–192
   Google Scholar
• Tauszig ME, Picker SM, Gathof BS. Platelet derived cytokine accumulation in platelet concentrates treated for pathogen reduction. Transfus Apher Sci 2012;46(1):33–37
   Google Scholar
• Picker SM, Speer R, Gathof BS. Functional characteristics of buffy-coat PLTs photochemically treated with amotosalen-HCl for pathogen inactivation. Transfusion 2004;44(3):320–329
   Web of Science ®Google Scholar
• Bekanntmachung der Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie) gemäß §§ 12 und 18 des Transfusionsgesetzes (TFG), (Änderungen und Ergänzungen 2010) vom 4. Mai 2010, Herausgegeben vom Bundesministerium der Justiz, Bundesanzeiger Nr. 101a, Jahrgang 62, 9. Juli 2010 (ISSN 0720-6100)
   Google Scholar
• Nogawa M, Naito Y, Chatani M, Onodera H, Shiba M, Okazaki H, Matsuzaki K, Satake M, Nakajima K, Tadokoro K. Parallel comparison of apheresis-collected platelet concentrates stored in four different additive solutions. Vox Sang 2013;105(4):305–312
   Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25(4):402–408
   PubMed Web of Science ®Google Scholar
• Perron MP, Landry P, Plante I, Provost P. Detection of human dicer and argonaute 2 catalytic activity. Methods Mol Biol 2011;725:121–141
   Google Scholar
• Wyant TL, Smith PC, Brown B, Kantor AB. Whole blood microvolume laser scanning cytometry for monitoring resting and activated platelets. Platelets 2001;12(5):309–318
   Web of Science ®Google Scholar
• Van Peer G, Mestdagh P, Vandesompele J. Accurate RT-qPCR gene expression analysis on cell culture lysates. Sci Rep 2012;2:222
   PubMed Web of Science ®Google Scholar
• Mason KD, Carpinelli MR, Fletcher JI, Collinge JE, Hilton AA, Ellis S, Kelly PN, Ekert PG, Metcalf D, Roberts AW, et al. Programmed anuclear cell death delimits platelet life span. Cell 2007;128(6):1173–1186
   PubMed Web of Science ®Google Scholar
• Vogler M, Hamali HA, Sun XM, Bampton ET, Dinsdale D, Snowden RT, Dyer MJ, Goodall AH, Cohen GM. BCL2/BCL-X(L) inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation. Blood 2011;117(26):7145–7154
   PubMed Web of Science ®Google Scholar
• Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996;7(2):157–161
   PubMed Web of Science ®Google Scholar
• Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, Massarotti EM, Remold-O'Donnell E, Farndale RW, Ware J, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010;327(5965):580–583
   PubMed Web of Science ®Google Scholar
• Laffont B, Corduan A, Ple H, Duchez AC, Cloutier N, Boilard E, Provost P. Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles. Blood 2013;122(2):253–261
   PubMed Web of Science ®Google Scholar
• Ple H, Maltais M, Corduan A, Rousseau G, Madore F, Provost P. Alteration of the platelet transcriptome in chronic kidney disease. Thromb Haemost 2012;108(4):605–615
   PubMed Web of Science ®Google Scholar
• Stakos DA, Gatsiou A, Stamatelopoulos K, Tselepis AD, Stellos K. Platelet microRNAs: From platelet biology to possible disease biomarkers and therapeutic targets. Platelets 2013;24(8):579–589
   PubMed Web of Science ®Google Scholar
• Risitano A, Beaulieu LM, Vitseva O, Freedman JE. Platelets and platelet-like particles mediate intercellular RNA transfer. Blood 2012;119(26):6288–6295
   PubMed Web of Science ®Google Scholar
• van Rhenen DJ, Vermeij J, Mayaudon V, Hind C, Lin L, Corash L. Functional characteristics of S-59 photochemically treated platelet concentrates derived from buffy coats. Vox Sang 2000;79(4):206–214
   Google Scholar
• Janetzko K, Lin L, Eichler H, Mayaudon V, Flament J, Kluter H. Implementation of the Intercept blood system for platelets into routine blood bank manufacturing procedures: Evaluation of apheresis platelets. Vox Sang 2004;86(4):239–245
   Google Scholar
• Bruchmuller I, Losel R, Bugert P, Corash L, Lin L, Kluter H, Janetzko K. Effect of the psoralen-based photochemical pathogen inactivation on mitochondrial DNA in platelets. Platelets 2005;16(8):441–445
   PubMed Web of Science ®Google Scholar
• Li J, Lockerbie O, de Korte D, Rice J, McLean R, Goodrich RP. Evaluation of platelet mitochondria integrity after treatment with Mirasol pathogen reduction technology. Transfusion 2005;45(6):920–926
   PubMed Web of Science ®Google Scholar
• Matarrese P, Straface E, Palumbo G, Anselmi M, Gambardella L, Ascione B, Del Principe D, Malorni W. Mitochondria regulate platelet metamorphosis induced by opsonized zymosan A–activation and long-term commitment to cell death. FEBS J 2009;276(3):845–856
   Google Scholar
• Zharikov S, Shiva S. Platelet mitochondrial function: From regulation of thrombosis to biomarker of disease. Biochem Soc Trans 2013;41(1):118–123
   PubMed Web of Science ®Google Scholar
• Keuren JF, Cauwenberghs S, Heeremans J, de Kort W, Heemskerk JW, Curvers J. Platelet ADP response deteriorates in synthetic storage media. Transfusion 2006;46(2):204–212
   Google Scholar
• Yuan JS, Reed A, Chen F, Stewart CN Jr. Statistical analysis of real-time PCR data. BMC Bioinformatics 2006;7:85
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009;136(2):215–233
   PubMed Web of Science ®Google Scholar